DEPLOYDatabase

Company

Fitbit

Biometric fitness-wearable brand (founded 2007; Google-owned since 2021) of the Charge/Sense/Versa devices with FDA-cleared ECG + AFib detection; now a Google…

Track FitbitGet notified of verified changes
Founded
2007
HQ
San Francisco, California, USA
Status
Google-owned (acquired 2021, ~$2.1B)

Models

1

Deployments

1

Overview

Biometric fitness-wearable brand (founded 2007; Google-owned since 2021) of the Charge/Sense/Versa devices with FDA-cleared ECG + AFib detection; now a Google product line (standalone smartwatch hardware deprioritized).

Verified record

Verified deployments
1 deployment on file
Active incidents
1 incident on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

Product

Fitbit Charge 6 / Sense 2 / Versa 4; ECG (2020) + PPG AFib (2022) FDA-cleared.

Status

Google product line; smartwatch hardware deprioritized but new 2026 trackers confirmed.

Acquisition

Google-owned since 2021

Company type

Biometric fitness-wearable brand

Data & sources

Press releases

1

Web sources

2

3 sources backing this record.View all →

Current platform

Fitbit (Charge / Sense / Versa)

Fitbit, founded in 2007 by James Park and Eric Friedman and acquired by Google in a roughly $2.1 billion deal that closed in January 2021, is now a Google product line rather than an independent company, and its devices are biometric-primary fitness bands and watches with atrial-fibrillation AI augmentation. Its current and last-generation devices include the Charge 6 from 2023, the Sense 2, and the Versa 4, carrying optical heart-rate sensing, ECG electrodes on the Sense line, a continuous electrodermal stress sensor on the Sense 2, blood oxygen, and skin temperature, plus Sleep Score, Sleep Profile, a Daily Readiness Score, and stress management. Its FDA clearances are the ECG app, cleared in September 2020 for on-demand assessment of atrial fibrillation versus sinus rhythm, and passive PPG-based Irregular Heart Rhythm Notifications, cleared on April 11, 2022 across a broad device range. Its blood oxygen, electrodermal stress, Sleep Score, and Daily Readiness features are wellness-grade and not FDA-cleared for any diagnostic claim. On current state, while standalone Fitbit-branded smartwatch hardware has been deprioritized with no Sense 3 and the smartwatch strategy consolidated onto the Pixel Watch, Google confirmed in October 2025 that new Fitbit hardware, expected to be trackers, is coming in 2026 along with a Fitbit Coach AI feature, so the line is deprioritized rather than dead. Its clinical-validation posture is the strongest in the cohort specifically on atrial fibrillation, anchored by the large prospective Fitbit Heart Study, while the 2026 Fitbit hardware specifications and the Fitbit Coach AI capabilities are unannounced and not verified.

biometricView model →

Fitbit on the deployment map

Where Fitbit's robots are verified operating. Explore the deployment map by place and type.

Relationships

Explainers

Plain-language answers to the questions people ask about Fitbit, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

  • What is Fitbit?

    Fitbit is Google's biometric wearable product line, distinct from the Pixel Watch generation. Current product line includes Fitbit Charge 6 + Fitbit Sense + Fitbit Versa, with ECG cleared 2020 and PPG-based AFib detection cleared 2022. Google acquired Fitbit in 2021; the Premium subscription model (~$9.99/month or $79.99/year) unlocks AI-insights across both Fitbit and Pixel Watch hardware. Per DEPLOY's biometric cluster framework, Fitbit anchors the budget-tier cleared archetype: cohort's strongest cardiologist-validation-at-price-point gradient with substantive FDA portfolio at sub-$200 hardware tier.

  • How does DEPLOY track the Fitbit Ionic burn recall?

    The Fitbit Ionic burn recall (CPSC 2022) operates as a canonical worked example of incident-tracking at primary-source verification depth. The U.S. Consumer Product Safety Commission (CPSC) issued a recall on the Fitbit Ionic smartwatch in March 2022 over reports of lithium-ion battery overheating causing burns; approximately 1 million units in the US (plus an additional ~700,000 units globally) were subject to the recall. The recall operates at CPSC primary-source verification depth (tier 3 primary-government-record per [DEPLOY's 9-tier source-quality rubric](/explainers/source-quality-rubric)); the Fitbit Ionic product line was discontinued by Fitbit as part of the recall remediation. Per [DEPLOY's biometric cluster framework](/explainers/biometric), the Ionic recall sits alongside the broader Fitbit entity scope: [Fitbit](/explainers/what-is-fitbit) anchors the budget-tier cleared archetype with strongest validation-at-price-point gradient; the Ionic incident affects a discontinued product line within the broader Fitbit portfolio. This piece documents the catch as framework-in-action worked example: incident-tracking discipline + CPSC primary-source verification + product-line discontinuation + within-entity verification-state distribution operating at editorial-anchor depth.

Safety record

1 recall on record (1 serious). Most recent: Mar 2022.

serious
1

Most recent: Mar 2022

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Fitbit (1)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operated deployments (1)

Operator customers (1)

Recent coverage

Fitbit in third-party press

Peer companies